Drug Shortage Report for IRBESARTAN/HCTZ
Report ID | 58073 |
Drug Identification Number | 02372908 |
Brand name | IRBESARTAN/HCTZ |
Common or Proper name | IRBESARTAN/HCTZ TAB |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
Strength(s) | 25MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-08-07 |
Estimated end date | 2018-08-31 |
Actual end date | 2018-09-04 |
Shortage status | Resolved |
Updated date | 2018-09-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-09-05 | English | Compare |
v4 | 2018-09-04 | French | Compare |
v3 | 2018-09-04 | English | Compare |
v2 | 2018-08-14 | French | Compare |
v1 | 2018-08-14 | English | Compare |
Showing 1 to 5 of 5